PIK3CA Mutations and BRCA1 Expression in Breast Cancer: Potential Biomarkers for Chemoresistance

Author： Santarpia Mariacarmela   Altavilla Giuseppe   Margeli Mireia   Cirauqui Beatriz   Mesiti Mario   Cavallari Vittorio   Ramirez Jose Luis   Sanchez-Ronco Maria   Santarpia Libero   Taron Miquel   Rosell Rafael  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.26, Iss.10, 2008-12, pp. : 1044-1051

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BRCA1 protein levels and PIK3CA mutations as predictive biomarkers for response to neoadjuvant chemotherapy in locally advanced breast cancer: An exploratory analysis

By                        

Oncology Letters, Vol. 4, Iss. 1, 2012-01 ,pp. : 141-145

Spandidos Publications

Access to resources Recommend Favorite

PIK3CA mutations in breast cancer are associated with poor outcome

By Li Shao   Rong Minna   Grieu Fabienne   Iacopetta Barry  

Breast Cancer Research and Treatment, Vol. 96, Iss. 1, 2006-03 ,pp. : 91-95

Springer Publishing Company

Access to resources Recommend Favorite

Mutations of the PIK3CA gene in ovarian and breast cancer

By Bellacosa Alfonso  

The Women's Oncology Review, Vol. 5, Iss. 4, 2005-12 ,pp. : 223-225

Informa Healthcare

Access to resources Recommend Favorite

PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis

By Aleskandarany Mohammed  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 45-53

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer

By Razis E.  

Breast Cancer Research and Treatment, Vol. 128, Iss. 2, 2011-07 ,pp. : 447-456

Springer Publishing Company

Access to resources Recommend Favorite